Patent attorney
European Patent and Trademark Attorney
Representative before the Unified Patent Court (UPC)
Dr. rer. nat. biotechnology
Molecular biology
Immunology
Pharmaceuticals
Nutrition
Melanie Neß has been working in the field of intellectual property law since 2018.
She studied biotechnology at RWTH Aachen University and completed her doctorate at the Institute for Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry at RWTH Aachen University Hospital.
After completing her training as a patent attorney, she worked in a large patent law firm in Munich.
She joined SKM-IP in June 2025 as a patent attorney specializing in biotechnology.
It is mainly active in the field of patent grant proceedings. This includes conducting searches, drafting applications and responding to official communications. She is also involved in opposition proceedings.
M. Neß, "Influence of endoglin on TGF-β1 regulated signal transduction pathways and functions of mast cells." Aachen: 2018.
Meurer SK, Neß M, Weiskirchen S, Kim P, Tag CG, Kauffmann M, Huber M, Weiskirchen R. Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from Mice. PLoS One. 2016 Jun 23;11(6)
Meurer, SK et al. "Hepatic stellate cells down-regulate pro-apoptotic effector abundance and secretion in mast cells." Journal of Gastroenterology 54 (2016): 1343 - 1404.
Neß, Melanie et al. "Regulation and profibrogenic effects of TGF-β1 signaling in mast cells, a cell type contributing to the outcome of hepatic injury." Journal of Gastroenterology 53 (2015): n. pag.
Neß, Melanie et al. "Impact of soluble endoglin on TGF-β1 mediated immediate early responses in HepG2 cells." (2014).